New Joint Therapies in Animals
As veterinarians we understand the complexity of disease processes associated with joint pain remains a constant dilemma in clinical practice and as with any disease process, an accurate diagnosis is…
Product Testimonial – Consider Arthramid Vet as a better treatment option for older patients or those with underlying metabolic disease.
Non-Pharmacological treatment offers veterinarians a better option for older and metabolic patients suffering from osteoarthritis (OA). Arthramid Vet’s 2.5% iPAAG technology is injected directly into the joint space providing lubrication…
Arthramid Vet: The last chance treatment that pulled through
Archie, a 7-year-old warmblood gelding on the brink of retirement due to persistent joint pain and inflammation has been given a second chance thanks to the innovative technology of the…
Arthramid Vet trumps traditional treatments for ‘gentle giant’ on the brink of retirement
Arthramid Vet has provided long-awaited relief and longevity of the career of Tarwin Grove Bellerive after soundness issues plagued his dressage career and threatened retirement as just a rising 8-year-old. Bumble, as…
Product Testimonial – Douglas The Truffle Dog
Douglas Terry Chief Truffle Dog at The Truffle Farm and advocate for Arthramid My name is Douglas and I am the chief hunter at The Truffle Farm. I started my…
From Young Horses to FEI Veterans: Arthramid Vet Delivers Performance for Sahar Daniel Hirosh
Wellington, FL (June 23, 2022) – Arthritis discomfort among dressage horses knows no age and no discipline! International Grand Prix rider Sahar Daniel Hirosh discovered this firsthand, when three of…
Japan Racing Association confirm no ban on the use of 2.5% polyacrylamide (PAAG) product Arthramid® Vet in Japan
Japan Racing Association (JRA) Anti-Doping Statement Regarding 2.5% PAAG Arthramid® Vet. The Japan Central Racing Association Feed and Drug Inspection Supervisory Committee Secretariat Anti-Doping Division, Horse Affairs Department have…
New technologies to aid in the treatment of osteoarthritis in dogs
Osteoarthritis (OA) is one of the most common chronic musculoskeletal diseases in dog populations, causing lameness and a loss of quality of life. It is estimated that 20-37% of dogs>…
Published Clinical Trial on the Efficacy of 2.5% PAAG Arthramid® Vet
This article is written for veterinarians, owners and trainers to summarise the major findings from a published study used for the listing of Arthramid Vet as a registered veterinary medicine in New Zealand and Australia. The…
Combining the use of 2.5% PAAG and Corticosteroids
Introduction Treatments in horses due to osteoarthritis traditionally include rest, controlled exercise, corrective shoeing, nutraceuticals (including glucosamine, epiitalis, hyaluronic acid, and PSGAG’s), non-steroidal anti-inflammatory drugs (NSAID’s), and any combination of…
Dr Florent David at Vet Fest Australia
View On Demand. VetFest Marketplace – A dedicated Industry Week for the Veterinary Profession View this 40 minute video presentation as Dr Florent David (DVM, MS, Dipl. ACVS & ECVS,…
Management of Joint Lameness in Competition and Sport Horses
Osteoarthritis (OA) is considered the most important musculoskeletal disorder in both humans and horses. From a clinical perspective it is associated with lameness and dysfunction of the affected joint, and…
